精品文档---下载后可任意编辑307 例Ⅰ B～Ⅱ A 期宫颈鳞癌患者的临床及预后分析开题报告摘要：本文旨在分析 307 例Ⅰ B～Ⅱ A 期宫颈鳞癌患者的临床特征和预后因素，为临床治疗提供参考。讨论对象为 2024 年至 2024 年在我院治疗的 307 例Ⅰ B～Ⅱ A 期宫颈鳞癌患者，收集并分析其临床资料和治疗结果。结果显示，307 例患者中约 80%为 40 岁以下女性，主要症状为阴道流血及白带异常。Ⅱ A 期患者较Ⅰ B 期患者多见，多数患者采纳手术治疗，术后放疗或化疗是常规治疗手段。随访期内，总体生存率为66.8%，5 年生存率为 62.6%。预后因素包括肿瘤大小、淋巴结转移、病理类型、治疗方案等。以上结果表明，宫颈鳞癌的发病人群较年轻，Ⅱ A 期患者较多。综合手术、放疗及化疗的多模式治疗常常为初期宫颈鳞癌的标准治疗方案。术后靶向相应预后因素进行治疗，对提高患者预后具有重要意义。关键词：宫颈鳞癌；Ⅰ B～Ⅱ A 期；临床特征；预后因素Abstract:The purpose of this study is to analyze the clinical features and prognostic factors of 307 patients with stage IIB to IIA cervical squamous cell carcinoma, and provide reference for clinical treatment.The study population consisted of 307 patients with stage IIB to IIA cervical squamous cell carcinoma treated in our hospital from 2024 to 2024. Clinical data and treatment outcomes were collected and analyzed.The results showed that about 80% of the 307 patients were women under 40 years of age, and the main symptoms were vaginal bleeding and abnormal white discharge. Stage IIA patients were more common than stage IIB patients, and most patients underwent surgery, followed by postoperative radiotherapy or chemotherapy. The overall survival rate was 66.8% during the follow-up period, and the 5-year survival rate was 62.6%. Prognostic factors included tumor size, lymph node metastasis, pathological type, and treatment regimen.精品文档---下载后可任意编辑These results indicate that cervical squamous cell carcinoma is more common in younger people, and stage IIA patients are more common. A comprehensive multimodal treatment consisting of surgery, radiotherapy, and chemotherapy is often the standard treatment for early-stage cervical squamous cell carcinoma. Targeted treatment based on corresponding prognostic factors after surgery is of great significance for improving patient prognosis.Keywords: cervical squamous cell carcinoma; stage IIB to IIA; clinical features; prognostic factors.
